Literature DB >> 22005288

Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ cells.

Guanqun Ge1, Puxun Tian, Hongbao Liu, Jin Zheng, Xiaohu Fan, Chenguang Ding, Zhankui Jin, Xiaohui Luo, Wujun Xue.   

Abstract

Immunoglobulin-like transcript 3 (ILT3) belongs to a family of inhibitory receptors with cytoplasmic immunoreceptor tyrosine based inhibitory motifs (ITIMs). Numerous studies have reported that increased ILT3 expression is associated with the tolerogenic properties of antigen-presenting cells (APCs) including dendritic cells (DCs). In this study, human CD34(+) hematopoietic stem/progenitor cells (HPSCs) were transduced with self-inactivating lentiviral vector carrying the ILT3 gene, and then induced to differentiate into DCs. Long-term and sustained transgene expression were observed. Importantly, DCs differentiated from ILT3-transduced HPSCs expressed high levels of human ILT3 and acquired strong tolerogenic capacity. This effect was associated with markedly decreased expression of co-stimulatory molecules (CD80, CD86) and down-regulation of NF-κB. Functionally, ILT3(high) DCs showed a reduced capacity to stimulate allogeneic T cell proliferation and increased the production of CD4(+)CD25(+)Foxp3(+) T regulatory cells with immunosuppressive activity. These results demonstrate that DCs derived from ILT3-transduced human CD34(+)HPSCs display tolerogenic properties to induce T regulatory cells in vitro.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005288     DOI: 10.1016/j.trim.2011.10.001

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  5 in total

1.  A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML.

Authors:  Samuel John; Heyu Chen; Mi Deng; Xun Gui; Guojin Wu; Weina Chen; Zunling Li; Ningyan Zhang; Zhiqiang An; Cheng Cheng Zhang
Journal:  Mol Ther       Date:  2018-08-07       Impact factor: 11.454

2.  Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.

Authors:  Pauline L de Goeje; Koen Bezemer; Marlies E Heuvers; Anne-Marie C Dingemans; Harry Jm Groen; Egbert F Smit; Henk C Hoogsteden; Rudi W Hendriks; Joachim Gjv Aerts; Joost Pjj Hegmans
Journal:  Oncoimmunology       Date:  2015-03-19       Impact factor: 8.110

3.  Molecular and functional heterogeneity of IL-10-producing CD4+ T cells.

Authors:  Leonie Brockmann; Shiwa Soukou; Babett Steglich; Paulo Czarnewski; Lilan Zhao; Sandra Wende; Tanja Bedke; Can Ergen; Carolin Manthey; Theodora Agalioti; Maria Geffken; Oliver Seiz; Sara M Parigi; Chiara Sorini; Jens Geginat; Keishi Fujio; Thomas Jacobs; Thomas Roesch; Jacob R Izbicki; Ansgar W Lohse; Richard A Flavell; Christian Krebs; Jan-Ake Gustafsson; Per Antonson; Maria Grazia Roncarolo; Eduardo J Villablanca; Nicola Gagliani; Samuel Huber
Journal:  Nat Commun       Date:  2018-12-21       Impact factor: 14.919

Review 4.  Human inhibitory leukocyte Ig-like receptors: from immunotolerance to immunotherapy.

Authors:  Calvin D De Louche; Ali Roghanian
Journal:  JCI Insight       Date:  2022-01-25

5.  LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia.

Authors:  Yasuaki Anami; Mi Deng; Xun Gui; Aiko Yamaguchi; Chisato M Yamazaki; Ningyan Zhang; Cheng Cheng Zhang; Zhiqiang An; Kyoji Tsuchikama
Journal:  Mol Cancer Ther       Date:  2020-09-02       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.